Skip to main navigation Skip to search Skip to main content

Evidence for Idarucizumab (praxbind) in the reversal of the direct thrombin inhibitor dabigatran: Review following the re-verse ad full cohort analysis

  • D'Youville College

Research output: Contribution to journalArticlepeer-review

9 Scopus citations
Original languageEnglish
Pages (from-to)692-698
Number of pages7
JournalP and T
Volume42
Issue number11
StatePublished - Nov 2017

Keywords

  • Anticoagulation
  • Dabigatran
  • Idarucizumab
  • Pradaxa
  • Praxbind
  • Reversal agent

Fingerprint

Dive into the research topics of 'Evidence for Idarucizumab (praxbind) in the reversal of the direct thrombin inhibitor dabigatran: Review following the re-verse ad full cohort analysis'. Together they form a unique fingerprint.

Cite this